|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.470 MYR | +0.36% |
|
+3.93% | -3.20% |
| 10/07 | IHH Healthcare Unit Liquidates Suzhou Industrial Park Yuan Hui Health Consulting | MT |
| 09/07 | IHH hospitals in India, Singapore saw fewer patients from Middle East due to war | RE |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1.71TCr | 1.8TCr | 2.09TCr | 2.44TCr | 2.57TCr | |||||
Gain (Loss) on Sale of Investment, Total (Rev) | 8.61Cr | - | - | - | - | |||||
Total Revenues | 1.72TCr | 1.8TCr | 2.09TCr | 2.44TCr | 2.57TCr | |||||
Cost of Goods Sold, Total | 1.12TCr | 1.18TCr | 1.39TCr | 1.61TCr | 1.72TCr | |||||
Gross Profit | 599.87Cr | 617.17Cr | 706.53Cr | 832.2Cr | 853.7Cr | |||||
Selling General & Admin Expenses, Total | 8.06Cr | 8.8Cr | 11Cr | 12Cr | 14Cr | |||||
Provision for Bad Debts | 8.06Cr | 4.47Cr | 9.92Cr | 7Cr | 9.9Cr | |||||
Depreciation & Amortization - (IS) | 126.76Cr | 135Cr | 146.22Cr | 167.4Cr | 183.8Cr | |||||
Amortization of Goodwill and Intangible Assets - (IS) | 4.73Cr | 4.95Cr | 4.77Cr | 5.3Cr | 5.3Cr | |||||
Other Operating Expenses | 144.04Cr | 187.4Cr | 119.36Cr | 257.15Cr | 258.7Cr | |||||
Other Operating Expenses, Total | 291.65Cr | 340.62Cr | 291.56Cr | 449.15Cr | 472.1Cr | |||||
Operating Income | 308.22Cr | 276.55Cr | 414.98Cr | 383.05Cr | 381.6Cr | |||||
Interest Expense, Total | -44Cr | -47Cr | -69Cr | -79Cr | -100.9Cr | |||||
Interest And Investment Income | 4.91Cr | 7.76Cr | 8.76Cr | 11Cr | 18Cr | |||||
Net Interest Expenses | -40Cr | -39Cr | -60Cr | -68Cr | -83Cr | |||||
Income (Loss) On Equity Invest. | 3.99Cr | 3.89Cr | 2.62Cr | 2.9Cr | 3.2Cr | |||||
Currency Exchange Gains (Loss) | -60Cr | -14Cr | -19Cr | 14Cr | -90L | |||||
Other Non Operating Income (Expenses) | 46Cr | 46Cr | 66Cr | 23Cr | -5.9Cr | |||||
EBT, Excl. Unusual Items | 257.71Cr | 272.19Cr | 403.83Cr | 355.05Cr | 294.8Cr | |||||
Merger & Related Restructuring Charges | -12.74L | - | -5L | -5L | -50L | |||||
Impairment of Goodwill | - | -15Cr | - | - | - | |||||
Gain (Loss) On Sale Of Investments | 9L | 10L | 30.95L | 60L | 1.4Cr | |||||
Gain (Loss) On Sale Of Assets | 1.5Cr | 1.19Cr | - | - | - | |||||
Asset Writedown | -8.22Cr | -37Cr | 83.77L | 20Cr | 6.9Cr | |||||
Other Unusual Items | 4.62Cr | - | - | - | 40Cr | |||||
EBT, Incl. Unusual Items | 255.57Cr | 221.71Cr | 404.93Cr | 375.6Cr | 342.8Cr | |||||
Income Tax Expense | 38Cr | 57Cr | 66Cr | 59Cr | 82Cr | |||||
Earnings From Continuing Operations | 217.66Cr | 164.51Cr | 339.1Cr | 316.2Cr | 260.7Cr | |||||
Net Income to Company | 217.66Cr | 164.51Cr | 339.1Cr | 316.2Cr | 260.7Cr | |||||
Minority Interest | -31Cr | -9.67Cr | -44Cr | -50Cr | -51Cr | |||||
Net Income - (IS) | 186.25Cr | 154.84Cr | 295.19Cr | 265.7Cr | 210.1Cr | |||||
Preferred Dividend and Other Adjustments | 8.83Cr | 5.22Cr | - | - | - | |||||
Net Income to Common Incl Extra Items | 177.42Cr | 149.62Cr | 295.19Cr | 265.7Cr | 210.1Cr | |||||
Net Income to Common Excl. Extra Items | 177.42Cr | 149.62Cr | 295.19Cr | 265.7Cr | 210.1Cr | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 0.2 | 0.17 | 0.34 | 0.3 | 0.24 | |||||
Basic EPS - Continuing Operations | 0.2 | 0.17 | 0.34 | 0.3 | 0.24 | |||||
Basic Weighted Average Shares Outstanding | 878.22Cr | 880.35Cr | 880.68Cr | 880.8Cr | 882.8Cr | |||||
Net EPS - Diluted | 0.2 | 0.17 | 0.34 | 0.3 | 0.24 | |||||
Diluted EPS - Continuing Operations | 0.2 | 0.17 | 0.34 | 0.3 | 0.24 | |||||
Diluted Weighted Average Shares Outstanding | 878.27Cr | 880.43Cr | 880.68Cr | 881.1Cr | 883Cr | |||||
Normalized Basic EPS | 0.15 | 0.18 | 0.24 | 0.19 | 0.15 | |||||
Normalized Diluted EPS | 0.15 | 0.18 | 0.24 | 0.19 | 0.15 | |||||
Dividend Per Share | 0.06 | 0.07 | 0.09 | 0.1 | 0.1 | |||||
Payout Ratio | 18.85 | 179.92 | 59.97 | 33.16 | 44.12 | |||||
Supplemental Items | ||||||||||
EBITDA | 407.81Cr | 380.52Cr | 526.91Cr | 512.35Cr | 525.5Cr | |||||
EBITA | 312.94Cr | 281.5Cr | 419.75Cr | 388.35Cr | 386.9Cr | |||||
EBIT | 308.22Cr | 276.55Cr | 414.98Cr | 383.05Cr | 381.6Cr | |||||
EBITDAR | 415.88Cr | 389.31Cr | 538.19Cr | 524.65Cr | 539.9Cr | |||||
Effective Tax Rate - (Ratio) | 14.84 | 25.8 | 16.26 | 15.81 | 23.95 | |||||
Total Current Taxes | 56Cr | 55Cr | 56Cr | 68Cr | 47Cr | |||||
Total Deferred Taxes | -21Cr | 2.08Cr | 9.37Cr | -8.5Cr | 35Cr | |||||
Normalized Net Income | 129.66Cr | 160.44Cr | 208.49Cr | 171.41Cr | 133.65Cr | |||||
Interest Capitalized | 2.71Cr | 2.61Cr | 58.74L | 50L | 1.2Cr | |||||
Interest on Long-Term Debt | 16Cr | 16Cr | 17Cr | 22Cr | 23Cr | |||||
Non-Cash Pension Expense | 75.99L | 1.74Cr | 1.83Cr | 2Cr | 4.7Cr | |||||
Supplemental Operating Expense Items | ||||||||||
Net Rental Expense, Total | 8.06Cr | 8.8Cr | 11Cr | 12Cr | 14Cr | |||||
Imputed Operating Lease Interest Expense | 2.7Cr | 3.23Cr | 6Cr | 6.27Cr | 7.76Cr | |||||
Imputed Operating Lease Depreciation | 5.36Cr | 5.57Cr | 5.28Cr | 6.03Cr | 6.64Cr | |||||
Stock-Based Comp., COGS (Total) | 59.42L | 33.19L | 77.14L | 50L | 10L | |||||
Total Stock-Based Compensation | 59.42L | 33.19L | 77.14L | 50L | 10L |
- Stock Market
- Stocks
- 5225 Stock
- Financials IHH Healthcare
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















